• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Predicting venous thromboembolism among hospitalized adults: a protocol for development and validation of an implementable real-time prognostic model.预测住院成人静脉血栓栓塞症:一个可实施的实时预后模型的开发与验证方案
Diagn Progn Res. 2025 Sep 8;9(1):19. doi: 10.1186/s41512-025-00205-8.
2
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.
5
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
6
Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.对有静脉血栓栓塞风险的住院患者实施血栓预防的干预措施。
Cochrane Database Syst Rev. 2018 Apr 24;4(4):CD008201. doi: 10.1002/14651858.CD008201.pub3.
7
Prediction of risk of recurrence of venous thromboembolism following treatment for a first unprovoked venous thromboembolism: systematic review, prognostic model and clinical decision rule, and economic evaluation.首次特发性静脉血栓栓塞症治疗后静脉血栓栓塞症复发风险的预测:系统评价、预后模型与临床决策规则以及经济学评估
Health Technol Assess. 2016 Feb;20(12):i-xxxiii, 1-190. doi: 10.3310/hta20120.
8
Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism.对有静脉血栓栓塞风险的住院内科和外科患者实施血栓预防的干预措施。
Cochrane Database Syst Rev. 2013 Jul 16(7):CD008201. doi: 10.1002/14651858.CD008201.pub2.
9
Does the Presence of Missing Data Affect the Performance of the SORG Machine-learning Algorithm for Patients With Spinal Metastasis? Development of an Internet Application Algorithm.缺失数据的存在是否会影响 SORG 机器学习算法在脊柱转移瘤患者中的性能?开发一种互联网应用算法。
Clin Orthop Relat Res. 2024 Jan 1;482(1):143-157. doi: 10.1097/CORR.0000000000002706. Epub 2023 Jun 12.
10
A New Measure of Quantified Social Health Is Associated With Levels of Discomfort, Capability, and Mental and General Health Among Patients Seeking Musculoskeletal Specialty Care.一种新的量化社会健康指标与寻求肌肉骨骼专科护理的患者的不适程度、能力以及心理和总体健康水平相关。
Clin Orthop Relat Res. 2025 Apr 1;483(4):647-663. doi: 10.1097/CORR.0000000000003394. Epub 2025 Feb 5.

本文引用的文献

1
Evaluating Bias-Mitigated Predictive Models of Perinatal Mood and Anxiety Disorders.评估围产期情绪和焦虑障碍的偏差缓解预测模型。
JAMA Netw Open. 2024 Dec 2;7(12):e2438152. doi: 10.1001/jamanetworkopen.2024.38152.
2
A real-time prognostic model for venous thromboembolic events among hospitalized adults.住院成人静脉血栓栓塞事件的实时预后模型
Res Pract Thromb Haemost. 2024 May 6;8(4):102433. doi: 10.1016/j.rpth.2024.102433. eCollection 2024 May.
3
TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods.TRIPOD+AI 声明:报告使用回归或机器学习方法的临床预测模型的更新指南。
BMJ. 2024 Apr 16;385:e078378. doi: 10.1136/bmj-2023-078378.
4
On the Nature of Informative Presence Bias in Analyses of Electronic Health Records.电子健康记录分析中信息性存在偏差的本质。
Epidemiology. 2022 Jan 1;33(1):105-113. doi: 10.1097/EDE.0000000000001432.
5
Risk assessment models for venous thromboembolism in hospitalised adult patients: a systematic review.住院成年患者静脉血栓栓塞症风险评估模型:系统评价。
BMJ Open. 2021 Jul 29;11(7):e045672. doi: 10.1136/bmjopen-2020-045672.
6
External validation of the simplified Geneva risk assessment model for hospital-associated venous thromboembolism in the Padua cohort.帕多瓦队列中用于医院相关性静脉血栓栓塞的简化日内瓦风险评估模型的外部验证
J Thromb Haemost. 2020 Mar;18(3):676-680. doi: 10.1111/jth.14688. Epub 2019 Dec 16.
7
Validation of clinical prediction models: what does the "calibration slope" really measure?临床预测模型的验证:“校准斜率”到底在衡量什么?
J Clin Epidemiol. 2020 Feb;118:93-99. doi: 10.1016/j.jclinepi.2019.09.016. Epub 2019 Oct 9.
8
Making Neighborhood-Disadvantage Metrics Accessible - The Neighborhood Atlas.让邻里劣势指标易于获取——邻里地图集。
N Engl J Med. 2018 Jun 28;378(26):2456-2458. doi: 10.1056/NEJMp1802313.
9
Multiple Imputation for Incomplete Data in Epidemiologic Studies.在流行病学研究中对不完全数据的多重插补。
Am J Epidemiol. 2018 Mar 1;187(3):576-584. doi: 10.1093/aje/kwx349.
10
Reasons for the persistent incidence of venous thromboembolism.静脉血栓栓塞持续发生的原因。
Thromb Haemost. 2017 Jan 26;117(2):390-400. doi: 10.1160/TH16-07-0509. Epub 2016 Dec 15.

预测住院成人静脉血栓栓塞症:一个可实施的实时预后模型的开发与验证方案

Predicting venous thromboembolism among hospitalized adults: a protocol for development and validation of an implementable real-time prognostic model.

作者信息

Domenico Henry J, Tillman Benjamin F, Just Shari L, Ko Yeji, Mixon Amanda S, Weitkamp Asli, Schildcrout Jonathan S, Walsh Colin, Ortel Thomas, French Benjamin

机构信息

Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.

Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

出版信息

Diagn Progn Res. 2025 Sep 8;9(1):19. doi: 10.1186/s41512-025-00205-8.

DOI:10.1186/s41512-025-00205-8
PMID:40916049
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12416065/
Abstract

BACKGROUND

Hospital-acquired venous thromboembolism (HA-VTE) is a leading cause of morbidity and mortality among hospitalized adults. Numerous prognostic models have been developed to identify those patients with elevated risk of HA-VTE. None, however, has met the necessary criteria to guide clinical decision-making. This study outlines a protocol for refining and validating a general-purpose prognostic model for HA-VTE, designed for real-time automation within the electronic health record (EHR) system.

METHODS

A retrospective cohort of 132,561 inpatient encounters (89,586 individual patients) at a large academic medical center will be collected, along with clinical and demographic data available as part of routine care. Data for temporal, geographic, and domain external validation cohorts will also be collected. Logistic regression will be used to predict occurrence of HA-VTE during an inpatient encounter. Variables considered for model inclusion will be based on prior demonstrated association with HA-VTE and their availability in both retrospective EHR data and routine clinical care. Least absolute shrinkage and selection operator (LASSO) with tenfold cross-validation will be used for initial variable selection. Variables selected by the LASSO procedure, along with those deemed necessary by clinicians, will be used in an unpenalized multivariable logistic regression model. Discrimination and calibration will be reported for the derivation and validation cohorts. Discrimination will be measured using Harrell's C statistic. Calibration will be measured using calibration intercept, calibration slope, Brier score, integrated calibration index, and visual examination of non-linear calibration curve. Model reporting will adhere to the Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis guidelines for clinical prediction models using machine learning methods (TRIPOD + AI).

DISCUSSION

We describe methods for developing, evaluating, and validating a prognostic model for HA-VTE using routinely collected EHR data. By combining best practices in statistical development and validation, knowledge engineering, and clinical domain knowledge, the resulting model should be well suited for real-time clinical implementation. Although this protocol describes our development of a model for HA-VTE, the general approach can be applied to other clinical outcomes.

摘要

背景

医院获得性静脉血栓栓塞症(HA-VTE)是住院成人发病和死亡的主要原因。已经开发了许多预后模型来识别那些发生HA-VTE风险升高的患者。然而,没有一个模型符合指导临床决策的必要标准。本研究概述了一个完善和验证HA-VTE通用预后模型的方案,该模型设计用于电子健康记录(EHR)系统中的实时自动化。

方法

将收集一家大型学术医疗中心132,561例住院病例(89,586名个体患者)的回顾性队列,以及作为常规护理一部分的临床和人口统计学数据。还将收集时间、地理和领域外部验证队列的数据。将使用逻辑回归来预测住院期间HA-VTE的发生。考虑纳入模型的变量将基于先前证明的与HA-VTE的关联以及它们在回顾性EHR数据和常规临床护理中的可用性。将使用具有十折交叉验证的最小绝对收缩和选择算子(LASSO)进行初始变量选择。通过LASSO程序选择的变量,以及临床医生认为必要的变量,将用于无惩罚多变量逻辑回归模型。将报告推导队列和验证队列的区分度和校准情况。区分度将使用Harrell's C统计量进行测量。校准将使用校准截距、校准斜率、Brier评分、综合校准指数以及非线性校准曲线的视觉检查进行测量。模型报告将遵循使用机器学习方法的临床预测模型的个体预后或诊断多变量预测模型的透明报告指南(TRIPOD + AI)。

讨论

我们描述了使用常规收集的EHR数据开发、评估和验证HA-VTE预后模型的方法。通过结合统计开发和验证、知识工程以及临床领域知识方面的最佳实践,所得模型应非常适合实时临床应用。尽管本方案描述了我们对HA-VTE模型的开发,但一般方法可应用于其他临床结局。